September 10, 2008
Todd Auman, PhD, has joined the UNC Institute for Pharmacogenomics and Individualized Therapy as a member of its research team.
Auman, a research assistant professor at the UNC Eshelman School of Pharmacy, is an expert in using genomic technologies to understand a patient’s response to gastrointestinal cancer therapy. He holds a doctorate in pharmacology and toxicology from Duke University and conducted postdoctoral research at the National Center for Toxicogenomics, located at the National Institute for Environmental Health Sciences.
The UNC Institute for Pharmacogenomics and Individualized Therapy, a research center within the Eshelman School of Pharmacy, is a unifying, programmatic structure that encourages and relies on a collaborative and interdisciplinary approach in its mission to tailor therapies and enable the delivery of individualized medical practice. Participating faculty are from the Schools of Pharmacy, Medicine, Public Health, and Nursing, along with those from the UNC Lineberger Comprehensive Cancer Center and the Carolina Center for Genome Sciences.
Latest News
Dean Angela Kashuba receives Carolina Alumni Faculty Service Award
RASP poster presentations capture student research
